AGTR1 and cancer: As a matter of fact, alternative G protein-independent pathways such as β-arrestin signaling may be relevant for cancer survival pathways, as β-Arrestin-biased AT1 stimulation activates MAPK pathway [43] and promotes cell survival during acute injury [44].